Howard Horn, Chief Financial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,785 shares at $40.40 ($72K) on 2025-03-06, disclosed to the SEC on 2025-03-10.
Open-market sale of $72k RARE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RARE | SELL | 2026-06-01 | $111K | — | Filing → |
| RARE | SELL | 2026-05-04 | $117K | — | Filing → |
| RARE | SELL | 2026-04-02 | $98K | — | Filing → |